The Val142Ile transthyretin cardiac amyloidosis: Not only an Afro-American pathogenic variant? A single-centre Italian experience

Journal of Cardiovascular Medicine

Volumn 17, Issue 2, 2016, Pages 122-125

  Cappelli, Francesco ^a   Frusconi, Sabrina ^a   Bergesio, Franco ^a   Grifoni, Elisa ^b   Fabbri, Alessia ^b   Giuliani, Costanza ^a   Falconi, Serena ^a   Bonifacio, Stefania ^a   Perfetto, Federico ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Hepatocyte derived transthyretin amyloidosis; Val122Ile; Val142Ile; White individuals

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BLOOD SAMPLING; CARDIAC PATIENT; CAUCASIAN; GENE FREQUENCY; GENE SEQUENCE; GENETIC VARIABILITY; HEART AMYLOIDOSIS; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE WALL; HUMAN; ITALIAN (CITIZEN); MAJOR CLINICAL STUDY; NEUROLOGIC EXAMINATION; NEW YORK HEART ASSOCIATION CLASS; PATHOGENESIS; PATIENT REFERRAL; SEQUENCE ANALYSIS; AMINO ACID SUBSTITUTION; FAMILIAL AMYLOID POLYNEUROPATHY; GENETICS; HEART DISEASE; ITALY; RETROSPECTIVE STUDY;

PREALBUMIN;

AGED; AMINO ACID SUBSTITUTION; AMYLOID NEUROPATHIES, FAMILIAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; HEART DISEASES; HUMANS; ITALY; PREALBUMIN; RETROSPECTIVE STUDIES;

EID: 84953356636     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0000000000000290     Document Type: Article

References (27)

1. Sekijima Y, Kelly JW, Ikeda S. Pathogenesis of and therapeutic strategies to ameliorate the transthyretin amyloidoses. Curr Pharm Des 2008; 14:3219-3230.
2. Ando Y, Ueda M. Diagnosis and therapeutic approaches to transthyretin amyloidosis. Curr Med Chem 2012; 19:2312-2323.
3. Ruberg FL, Berk JL Transthyretin (TTR) cardiac amyloidosis. Circulation 2012; 126:1286-1300.
4. Perfetto F, Cappelli F, Bergesio F., et al. Cardiac amyloidosis: the heart of the matter. Intern Emerg Med 2013; 8:191-203.
5. Holmgren G, Steen L, Ekstedt J., et al. Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30). Clin Genet 1991; 40:242-246.
6. Ong DE, Davis JT, O'Day WT, Bok D. Synthesis and secretion of retinolbinding protein and transthyretin by cultured retinal pigment epithelium. Biochemistry 1994; 33:1835-1842.
7. Nakazato M, Kangawa K, Kurihara T., Matsukura S, Matsuo H. Variant transthyretin in cerebrospinal fluid in familial amyloidotic polyneuropathy. J Neurol Sci 1987; 79:111-116.
8. Planté-Bordeneuve V, Said G. Familial amyloid polyneuropathy. Lancet Neurol 2011; 10:1086-1097.
9. Saraiva MJ, Magalhaes J, Ferreira N., Almeida MR. Transthyretin deposition in familial a amyloidotic polyneuropathy. Curr Med Chem 2012; 19:2304-2311.
10. Coelho T. Familial amyloid polyneuropathy: new developments in genetics and treatment. Curr Opin Neurol 1996; 9:355-359.
11. Dungu JN, Anderson LJ, Whelan C.J., Hawkins PN. Cardiac transthyretin amyloidosis. Heart 2012; 98:1546-1554.
12. Dharmarajan K, Maurer MS Transthyretin cardiac amyloidoses in older North Americans. J Am Geriatr Soc 2012; 60:765-774.
13. Buxbaum J, Alexander A, Koziol J., Tagoe C, Fox E, Kitzman D. Significance of the amyloidogenic transthyretin Val 122 Ile allele in African Americans in the Arteriosclerosis Risk in Communities (ARIC) and Cardiovascular Health (CHS) Studies. Am Heart J 2010; 159:864-870.
14. Connors LH, Lim A, Prokaeva T., Roskens VA, Costello CE. Tabulation of human transthyretin (TTR) variants, 2003. Amyloid 2003; 10:160-184.
15. The Human gene mutation database (HGMD database). http://www.hgmd.org. [Last accessed 3 December 2014].
16. Hrnsten R, Pennlert J, Wiklund U., Lindqvist P, Jensen SM, Suhr OB Heart complications in familial transthyretin amyloidosis: impact of age and gender. Amyloid 2010; 17:63-68.
17. Rapezzi C, Quarta CC, Riva L, et al Transthyretin-related amyloidoses and the heart: a clinical overview. Nat Rev Cardiol 2010; 7:398-408.
18. HGVS. Nomenclature for the description of sequence variations homepage. http://www.hgvs.org/mutnomen/. [Last accessed 3 December 2014].
19. Yamashita T, Hamidi Asl K, Yazaki M, Benson MD A prospective evaluation of the transthyretin Ile142 allele frequency in an African-American population. Amyloid 2005; 12:127-130.
20. Gillmore JD, Booth DR, Pepys M.B., Hawkins PN. Hereditary cardiac amyloidosis associated with the transthyretin Ile142 pathogenic variant in a white man. Heart 1999; 82:e2.
21. Hamidi Asl K., Nakamura M, Yamashita T., Benson MD. Cardiac amyloidosis associated with the transthyretin Ile142 pathogenic variant in a Caucasian family. Amyloid 2001; 8:263-269.
22. Ammirati E, Marziliano N, Vittori C., et al. The first Caucasian patient with p. Val142Ile mutated-transthyretin cardiac amyloidosis treated with isolated heart transplantation. Amyloid 2012; 19:113-117.
23. Auer PL. et al. Imputation of exome sequence variants into population-based samples and blood-cell-trait-associated loci in African Americans: NHLBI GO Exome Sequencing Project. Am J Hum Genet 2012; 91:794-808.
24. Gertz MA, Comenzo R, Falk R.H., et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th international symposium on amyloid and amyloidosis. Am J Hematol 2005; 79:319-328.
25. Arruda-Olson A.M., Zeldenrust SR, Dispenzieri A, et al Genotype, echocardiography, and survival in familial transthyretin amyloidosis. Amyloid 2013; 20:263-268.
26. Cooper DN, Mort M, Stenson P.D., Balland EV, Chuzhanova NV. Methylation-mediated deamination of 5-methylcytosine appears to give rise to mutations causing human inherited disease in CpNpG trinucleotides, as well as in CpG dinucleotides. Human Genomics 2010; 4:406-410.
27. Perfetto F, Cappelli F, Bergesio F. Asymptomatic homozygous gene carrier in a family with Ile68Leu ATTR amyloidosis: a new endemic region in northern Tuscany? J Cardiovasc Med (Hagerstown) 2011; 12:450-451.